Hepatitis B Annual
Home

Current Issue  

Back Issues   

Instructions   

Search Login    Users online: 263 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
>>> Ahead of Print <<<
CASE REPORT
Year : 2009  |  Volume : 6  |  Issue : 1  |  Page : 157-162

Efficacy and safety of telbivudine during pregnancy in a patient with HBeAg-Negative chronic Hepatitis B


Department of Gastroenterology, Apollo Hospitals, Chennai - 600 006, India

Correspondence Address:
Arumugam T Mohan
Sabari, W-6, I.C.C., Annanagar West Ext., Chennai - 600 101
India
Login to access the Email id

Source of Support: Novartis Pharma AG, Conflict of Interest: None


DOI: 10.4103/0972-9747.76912

Rights and Permissions

Managing chronic hepatitis B (CHB) during pregnancy remains a challenging task as there is no information on the consequences to the fetus. Telbivudine, an oral nucleoside analog (NA), is a potential therapeutic option during pregnancy, but clinical experience is lacking. We report on the safety and efficacy of telbivudine 600 mg/day administered to a 20-year-old Indian woman with hepatitis B e antigen negative CHB, who became pregnant during treatment. Telbivudine was continued with monitoring of maternal hepatitis B virus (HBV) DNA and alanine aminotransferase (ALT) levels during pregnancy and after delivery. The patient maintained polymerase chain reaction (PCR) undetectable HBV DNA and normal ALT levels with telbivudine throughout pregnancy. At birth, HBV DNA was undetectable by PCR in the newborn. No congenital abnormalities were noted. In conclusion, telbivudine therapy during pregnancy was effective in maintaining undetectable viremia, and no safety concerns were noted in the mother and child. Additional clinical studies are warranted.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed6079    
    Printed568    
    Emailed0    
    PDF Downloaded1056    
    Comments [Add]    

Recommend this journal